binance left Huobi Global Coinmarketcap net_left Phương Thức Thanh Toán
Phương Thức Thanh Toán

Roche believes cancer drug setback not a fatal blow to growth prospects

By Ludwig Burger and Paul Arnold ZURICH (Reuters) -Roche Holding AG has enough in its drug development pipeline to make up for the recent setback of its keenly-watched...
Roche believes cancer drug setback not a fatal blow to growth prospects © Reuters. FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020. REUTERS/Arnd Wiegmann/File Photo

By Ludwig Burger and Paul Arnold

ZURICH (Reuters) -Roche Holding AG has enough in its drug development pipeline to make up for the recent setback of its keenly-watched experimental cancer drug, Chairman Christoph Franz said on Thursday.

On Wednesday, the Swiss drugmaker's stock had its worst day since March 2020, after an interim analysis of an ongoing clinical trial showed its drug, tiragolumab, failed to meaningfully slow disease progression in patients with the most common form of lung cancer.

It was the second tiragolumab trial that fell short of expectations.

"There are always setbacks, we are used to that. We of course had growth expectations, which have for now been disappointed," said Franz, who heads the family-controlled company's board of directors.

The advantage of a company the size of Roche is that there are several late-stage trials that the company is also banking on to enrich its growth prospects, he suggested.

One particularly high-risk, high reward prospect in the company's arsenal is its experimental Alzheimer's drug, gantenerumab. Franz sought to temper expectations that trial results for gantenerumab, expected later this year, would make up for this week's disappointment.

The field targeting the memory-robbing disease - which affects millions of people globally - is littered with high profile failures.

Adoption of the first new Alzheimer's treatment in nearly 20 years, made by rival U.S. drugmaker Biogen Inc (NASDAQ:BIIB), spectacularly underwhelmed after the U.S. health regulator green lit the treatment without clear evidence of patient benefit, driven in part by the lack of options for the fatal mind-wasting disease.

"Everyone knows Alzheimer's research is a very risky type of research," Franz said.

Roche is hoping that its blood cancer drug, glofitamab, will bolster growth prospects alongside a growing demand for its other prime focus - diagnostics.

The world's biggest cancer drug maker is poised to pioneer the use of mass spectrometry in healthcare diagnostics, a method so far only used in research.

"Many of our competitors probably balk at the investment," Franz said.

Others investments can come in the form of deals. Franz suggested the company remains open to acquiring assets to promote growth.

Drugmakers often go shopping to reinvigorate their pipelines, and the recent downturn in the biotech sector means M&A targets that were once considered too expensive are now within reach.

Roche has about $16 billion in its coffers, according to a note from Jefferies analysts earlier this month.

"Over the last few years we were confronted with market prices that did not leave any room for commercial viability," Franz said of acquiring drugs from others through deals or acquisitions.

"If prices are now becoming more attractive, that could also affect our interest."

Hot Auto Trade Bot ig right nyse right Neteller Phương Thức Thanh Toán
BROKERS ĐƯỢC CẤP PHÉP
rakuten_main right top net_home_top Ai VIF Binance _ main right top fbs_main right top tifia_main right top
23-05-2022 09:03:55 (UTC+7)

EUR/USD

1.0588

+0.0028 (+0.27%)

Summary

↑ Buy

Moving Avg:

Buy (12)

Sell (0)

Indicators:

Buy (6)

Sell (1)

EUR/USD

1.0588

+0.0028 (+0.27%)

Summary

↑ Buy

Moving Avg:

Buy (12)

Sell (0)

Indicators:

Buy (6)

Sell (1)

GBP/USD

1.2533

+0.0046 (+0.37%)

Summary

↑ Buy

Moving Avg:

Buy (12)

Sell (0)

Indicators:

Buy (8)

Sell (0)

USD/JPY

127.35

-0.51 (-0.40%)

Summary

↑ Sell

Moving Avg:

Buy (3)

Sell (9)

Indicators:

Buy (2)

Sell (8)

AUD/USD

0.7082

+0.0050 (+0.70%)

Summary

↑ Buy

Moving Avg:

Buy (9)

Sell (3)

Indicators:

Buy (8)

Sell (1)

USD/CAD

1.2809

-0.0027 (-0.21%)

Summary

↑ Buy

Moving Avg:

Buy (7)

Sell (5)

Indicators:

Buy (9)

Sell (1)

EUR/JPY

134.83

-0.18 (-0.13%)

Summary

↑ Sell

Moving Avg:

Buy (1)

Sell (11)

Indicators:

Buy (3)

Sell (5)

EUR/CHF

1.0295

-0.0001 (-0.01%)

Summary

Neutral

Moving Avg:

Buy (6)

Sell (6)

Indicators:

Buy (5)

Sell (3)

Gold Futures

1,848.57

+6.47 (+0.35%)

Summary

Neutral

Moving Avg:

Buy (6)

Sell (6)

Indicators:

Buy (5)

Sell (2)

Silver Futures

21.843

+0.169 (+0.78%)

Summary

Sell

Moving Avg:

Buy (5)

Sell (7)

Indicators:

Buy (2)

Sell (4)

Copper Futures

4.3030

-0.0012 (-0.03%)

Summary

Sell

Moving Avg:

Buy (4)

Sell (8)

Indicators:

Buy (1)

Sell (3)

Crude Oil WTI Futures

110.87

+0.59 (+0.54%)

Summary

Neutral

Moving Avg:

Buy (7)

Sell (5)

Indicators:

Buy (1)

Sell (5)

Brent Oil Futures

110.71

+0.72 (+0.65%)

Summary

Sell

Moving Avg:

Buy (6)

Sell (6)

Indicators:

Buy (1)

Sell (6)

Natural Gas Futures

8.165

-0.235 (-2.80%)

Summary

↑ Sell

Moving Avg:

Buy (5)

Sell (7)

Indicators:

Buy (1)

Sell (6)

US Coffee C Futures

216.48

-2.22 (-1.02%)

Summary

↑ Buy

Moving Avg:

Buy (12)

Sell (0)

Indicators:

Buy (6)

Sell (0)

Euro Stoxx 50

3,657.03

+16.48 (+0.45%)

Summary

↑ Buy

Moving Avg:

Buy (7)

Sell (5)

Indicators:

Buy (9)

Sell (1)

S&P 500

3,901.36

+0.57 (+0.01%)

Summary

↑ Buy

Moving Avg:

Buy (12)

Sell (0)

Indicators:

Buy (8)

Sell (0)

DAX

13,981.91

+99.61 (+0.72%)

Summary

Buy

Moving Avg:

Buy (6)

Sell (6)

Indicators:

Buy (8)

Sell (0)

FTSE 100

7,389.98

+87.24 (+1.19%)

Summary

Neutral

Moving Avg:

Buy (3)

Sell (9)

Indicators:

Buy (7)

Sell (2)

Hang Seng

20,520.00

-197.24 (-0.95%)

Summary

↑ Sell

Moving Avg:

Buy (0)

Sell (12)

Indicators:

Buy (0)

Sell (9)

US Small Cap 2000

1,773.27

-2.96 (-0.17%)

Summary

↑ Buy

Moving Avg:

Buy (7)

Sell (5)

Indicators:

Buy (7)

Sell (1)

IBEX 35

8,484.50

+78.50 (+0.93%)

Summary

Neutral

Moving Avg:

Buy (3)

Sell (9)

Indicators:

Buy (5)

Sell (2)

BASF SE NA O.N.

48.850

-0.010 (-0.02%)

Summary

Buy

Moving Avg:

Buy (6)

Sell (6)

Indicators:

Buy (6)

Sell (1)

Bayer AG NA

63.74

+0.34 (+0.54%)

Summary

Buy

Moving Avg:

Buy (6)

Sell (6)

Indicators:

Buy (6)

Sell (2)

Allianz SE VNA O.N.

195.58

+0.78 (+0.40%)

Summary

Buy

Moving Avg:

Buy (6)

Sell (6)

Indicators:

Buy (8)

Sell (0)

Adidas AG

172.80

+0.92 (+0.54%)

Summary

Buy

Moving Avg:

Buy (6)

Sell (6)

Indicators:

Buy (7)

Sell (1)

Deutsche Lufthansa AG

6.852

+0.049 (+0.72%)

Summary

↑ Sell

Moving Avg:

Buy (0)

Sell (12)

Indicators:

Buy (2)

Sell (5)

Siemens AG Class N

115.08

+2.62 (+2.33%)

Summary

Neutral

Moving Avg:

Buy (3)

Sell (9)

Indicators:

Buy (4)

Sell (4)

Deutsche Bank AG

9.362

-0.130 (-1.37%)

Summary

Buy

Moving Avg:

Buy (6)

Sell (6)

Indicators:

Buy (8)

Sell (1)

 EUR/USD1.0588↑ Buy
 GBP/USD1.2533↑ Buy
 USD/JPY127.35↑ Sell
 AUD/USD0.7082↑ Buy
 USD/CAD1.2809↑ Buy
 EUR/JPY134.83↑ Sell
 EUR/CHF1.0295Neutral
 Gold1,848.57Neutral
 Silver21.843Sell
 Copper4.3030Sell
 Crude Oil WTI110.87Neutral
 Brent Oil110.71Sell
 Natural Gas8.165↑ Sell
 US Coffee C216.48↑ Buy
 Euro Stoxx 503,657.03↑ Buy
 S&P 5003,901.36↑ Buy
 DAX13,981.91Buy
 FTSE 1007,389.98Neutral
 Hang Seng20,520.00↑ Sell
 Small Cap 20001,773.27↑ Buy
 IBEX 358,484.50Neutral
 BASF48.850Buy
 Bayer63.74Buy
 Allianz195.58Buy
 Adidas172.80Buy
 Lufthansa6.852↑ Sell
 Siemens AG115.08Neutral
 Deutsche Bank AG9.362Buy
Mua/Bán 1 chỉ SJC
# So hôm qua # Chênh TG
SJC Eximbank6,880/ 6,980
(5/ 5) # 1,787
SJC HCM6,895/ 6,985
(0/ 0) # 1,791
SJC Hanoi6,895/ 6,987
(0/ 0) # 1,793
SJC Danang6,895/ 6,987
(0/ 0) # 1,793
SJC Nhatrang6,895/ 6,987
(0/ 0) # 1,793
SJC Cantho6,895/ 6,987
(0/ 0) # 1,793
Cập nhật 23-05-2022 09:03:57
Xem lịch sử giá vàng SJC: nhấn đây!
ↀ Giá vàng thế giới
$1,849.42+2.740.15%
Live 24 hour Gold Chart
ʘ Giá bán lẻ xăng dầu
Sản phẩmVùng 1Vùng 2
RON 95-V30.58031.190
RON 95-III29.98030.570
E5 RON 92-II28.95029.520
DO 0.05S26.65027.180
DO 0,001S-V27.45027.990
Dầu hỏa 2-K25.16025.660
ↂ Giá dầu thô thế giới
WTI$110.77-0.24-0.22%
Brent$113.23-0.34-0.30%
$ Tỷ giá Vietcombank
Ngoại tệMua vàoBán ra
USD23.005,0023.315,00
EUR23.899,8625.238,69
GBP28.277,1029.483,51
JPY176,47186,83
KRW15,8019,25
Cập nhật lúc 08:57:42 23/05/2022
Xem bảng tỷ giá hối đoái
binance main right Fxpro Main Right aetos main right Phương Thức Thanh Toán